PAAT Act

This bill would change Medicare Part D, the program that covers prescription drugs for people on Medicare. Starting in 2027, Medicare drug plans would have to include every covered drug that is prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease. Starting with plan years on or after January 1, 2027, Medicare drug plans and Medicare Advantage drug plans could not require prior authorization for these drugs more than once in any 12-month period. This limit would not apply to drugs typically used for 12 months or less, certain controlled drugs such as opioids and benzodiazepines, or drugs that require a federal risk safety program.

Full text and official record on Congress.gov

Sponsors

• Julie Johnson Democrat sponsor
• 5 cosponsors